Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vilhelmas Landsbergis

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cureus|June 12, 2024
Hide-and-Seek With Spindle-Cell-Component-Poor Metaplastic ThymomaGintarė Ražanskienė, Vilhelmas Landsbergis, Vytenis Bertašius, et al.
Frontiers in Oncology|June 25, 2026
Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvementMilda Mikalonytė, Vilhelmas Landsbergis, Lukas Kevličius, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cureus|June 12, 2024
Hide-and-Seek With Spindle-Cell-Component-Poor Metaplastic ThymomaGintarė Ražanskienė, Vilhelmas Landsbergis, Vytenis Bertašius, et al.
Frontiers in Oncology|June 25, 2026
Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvementMilda Mikalonytė, Vilhelmas Landsbergis, Lukas Kevličius, et al.
Pageof 1